Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors

Arthritis and Rheumatism

Volumn 60, Issue 10, 2009, Pages 3091-3097

  Llanos, Carolina ^a   Izmirly, Peter M ^a   Katholi, Margaret ^a   Clancy, Robert M ^a   Friedman, Deborah M ^b   Kim, Mimi Y ^c   Buyon, Jill P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RO ANTIBODY; STEROID;

ARTICLE; AUTOIMMUNE DISEASE; BIRTH; CHILD; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FETUS; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL WELFARE; MOTHER; MOTHER FETUS RELATIONSHIP; NEONATAL LUPUS; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

AUTOANTIBODIES; AUTOANTIGENS; COHORT STUDIES; FEMALE; HEART DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREGNANCY; PREGNANCY OUTCOME; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 70349766892     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24768     Document Type: Article

References (29)

1. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001;37:238-242 (Pubitemid 32051745)
2. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti-Ro and anti-La antibody- associated endocardial fibroelastosis. Circulation 2002;105:843-848
3. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-1835 (Pubitemid 32758230)
4. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120:544-551 (Pubitemid 24091594)
5. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-1666 (Pubitemid 28273312)
6. Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, et al, for the PRIDE Investigators. Utility of cardiac monitoring in fetuses at risk for congenital heart block. The PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008;117:485-493
7. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren- Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004;50:1253-1261 (Pubitemid 38480837)
8. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti SSA/Ro-SSB/La antibodies. Lupus 2002;11:145-151 (Pubitemid 34296929)
9. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-680 (Pubitemid 30840126)
10. Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A, et al. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004;3:2480-2487 (Pubitemid 39603101)
11. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-1241 (Pubitemid 34525831)
12. Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, et al. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005;52:3079-3086 (Pubitemid 41447089)
13. Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S, Bremme K, et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008;154:30-37
14. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993;36:1263-1273 (Pubitemid 23303117)
15. Tseng CE, Caldwell K, Feit S, Chan EK, Buyon JP. Subclass distribution of maternal and neonatal anti-Ro (SSA) and La (SSB) antibodies in congenital heart block. J Rheumatol 1996;23:925-932 (Pubitemid 26157772)
16. Donald A, Donner A. Adjustments to the Mantel-Haenszel chisquare statistic and odds ratio variance estimator when the data are clustered [published erratum appears in Stat Med 1997;16: 2927-8]. Stat Med 1987;6:491-499
17. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003;62:1010-1012 (Pubitemid 37159504)
18. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-957 (Pubitemid 29247102)
19. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EK. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjögren's syndrome. J Immunol 1994;152:3675-3684
20. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001;44:487-488 (Pubitemid 32207045)
21. Srinivasan S, Strasburger J. Overview of fetal arrhythmias. Curr Opin Pediatr 2008;20;522-531
22. Gladman G, Silverman ED, Yuk-Law, Luy L, Boutin C, Laskin C, et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol 2002;19: 73-80. (Pubitemid 34229582)
23. Solomon DG, Rupel A, Buyon JP. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 2003; 12:646-647 (Pubitemid 37021804)
24. Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 2007;9:101-108 (Pubitemid 46932715)
25. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 2007;33:267-285
26. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/ Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36:120-128
27. Harmon CE, Lee LA, Huff JC, Norris DA, Weston WL. The frequency of autoantibodies to the SS-A/Ro antigen in pregnancy sera [abstract]. Arthritis Rheum 1984;27 Suppl 4:S20.
28. Siren MK, Julkunen H, Kaaja R. The increasing incidence of isolated congenital heart block in Finland. J Rheumatol 1998;25: 1862-1864 (Pubitemid 28439289)
29. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-αand TGF-β1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003; 171:3253-3261 (Pubitemid 37093552)